RiverVest Venture Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
11

- Investments
-
163
- Portfolio
-
20
- Exits
-
51

RiverVest Venture Partners General Information
Company Description
Founded in 2000, RiverVest Venture Partners is a venture capital firm headquartered in Saint Louis, Missouri. The firm seeks to invest in companies operating in the biopharma and medical device sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.rivervest.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 101 South Hanley Road
- Suite 1850
- Saint Louis, MO 63105
- United States
RiverVest Venture Partners Investments (163)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Biolinq | 22-Apr-2025 | Later Stage VC | Monitoring Equipment | Clinical Trials - Phase 2 | ||
Glycomine | 16-Apr-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
Atalanta Therapeutics | 28-Jan-2025 | Drug Discovery | Pre-Clinical Trials | |||
Alleviant Medical | 14-Jan-2025 | Therapeutic Devices | Clinical Trials - General | |||
InterVene | 07-Oct-2024 | Surgical Devices | Generating Revenue | |||
Biolinq | 29-Aug-2024 | Monitoring Equipment | Clinical Trials - Phase 2 | |||
Bluejay Therapeutics | 09-May-2024 | Drug Discovery | Generating Revenue | |||
Engrail Therapeutics | 14-Mar-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
Avalyn Pharma | 22-Sep-2023 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
Maxwell Biomedical | 02-Jun-2023 | Early Stage VC | Therapeutic Devices | Clinical Trials - Phase 1 |
RiverVest Venture Partners Exits (51)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
SeQure DX | 29-Jan-2025 | Merger/Acquisition | |
Arch Oncology | 31-May-2024 | ||
Scout Bio | 25-Jan-2024 | ||
Cardialen | 14-Dec-2022 | ||
Standard Bariatrics | 27-Sep-2022 | ||
Good Therapeutics | 18-Aug-2022 | ||
Altius (Therapeutic Devices) | 01-Aug-2022 | ||
Adarza BioSystems | 01-May-2022 | ||
Smart Wires | 17-May-2021 | IPO | |
Reneo Pharmaceuticals | 09-Apr-2021 | IPO |
RiverVest Venture Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
RiverVest Venture Partners Investments by Industry, Year, and Region
RiverVest Venture Partners Co-Investors (158)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Digitalis Ventures | 4 |
![]() |
![]() |
||
Novo Holdings |
![]() |
![]() |
|||
Abingworth |
![]() |
![]() |
|||
American Century Investments |
![]() |
![]() |
|||
Roche Venture Fund |
![]() |
![]() |
RiverVest Venture Partners FAQs
-
What is RiverVest Venture Partners?
Founded in 2000, RiverVest Venture Partners is a venture capital firm headquartered in Saint Louis, Missouri.
-
When was RiverVest Venture Partners founded?
RiverVest Venture Partners was founded in 2000.
-
Where is RiverVest Venture Partners headquartered?
RiverVest Venture Partners is headquartered in Saint Louis, MO.
-
What is RiverVest Venture Partners's total asset value?
RiverVest Venture Partners has around
in total assets under management. -
How many investments has RiverVest Venture Partners made?
RiverVest Venture Partners has made 163 investments.
-
What has RiverVest Venture Partners invested in?
RiverVest Venture Partners has made numerous investments in companies like Biolinq, Glycomine, and Atalanta Therapeutics within the Monitoring Equipment and Drug Discovery industries.
-
What has RiverVest Venture Partners invested in recently?
RiverVest Venture Partners's latest investment was on 22-Apr-2025 in Biolinq, a company within the Monitoring Equipment industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »